Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease

BACKGROUND: Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) comprises the triad of chronic rhinosinusitis with nasal polyps, asthma and intolerance to NSAIDs. Dupilumab treatment, targeting the interleukin-4 (IL-4) receptor α, significantly reduces polyp burden as...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Sven, Poglitsch, Katharina, Morgenstern, Christina, Quint, Tamara, Gangl, Katharina, Sinz, Christoph, Bartosik, Tina, Campion, Nicholas James, Liu, David Tianxiang, Landegger, Lukas David, Tu, Aldine, Stanek, Victoria, Rocha-Hasler, Marianne, Bangert, Christine, Eckl-Dorna, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017890/
https://www.ncbi.nlm.nih.gov/pubmed/36549708
http://dx.doi.org/10.1183/13993003.01335-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017890/
https://www.ncbi.nlm.nih.gov/pubmed/36549708
http://dx.doi.org/10.1183/13993003.01335-2022

Ejemplares similares